| Literature DB >> 28692295 |
Andrew P Crew1, Kanak Raina1, Hanqing Dong1, Yimin Qian1, Jing Wang1, Dominico Vigil1, Yevgeniy V Serebrenik, Brian D Hamman1, Alicia Morgan1, Caterina Ferraro1, Kam Siu1, Taavi K Neklesa1, James D Winkler1, Kevin G Coleman1, Craig M Crews.
Abstract
Proteolysis targeting chimeras (PROTACs) are bifunctional molecules that recruit an E3 ligase to a target protein to facilitate ubiquitination and subsequent degradation of that protein. While the field of targeted degraders is still relatively young, the potential for this modality to become a differentiated and therapeutic reality is strong, such that both academic and pharmaceutical institutions are now entering this interesting area of research. In this article, we describe a broadly applicable process for identifying degrader hits based on the serine/threonine kinase TANK-binding kinase 1 (TBK1) and have generalized the key structural elements associated with degradation activities. Compound 3i is a potent hit (TBK1 DC50 = 12 nM, Dmax = 96%) with excellent selectivity against a related kinase IKKε, which was further used as a chemical tool to assess TBK1 as a target in mutant K-Ras cancer cells.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28692295 DOI: 10.1021/acs.jmedchem.7b00635
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446